1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.
Stephen MacMillan

250 Campus Dr
Marlborough, Massachusetts 01752-3020
Phone: 15082632900


Hologic: Prospects For Growth As Headwinds Disappear
Feb 11, 2024 15:54pm

No summary available.

Source:Seeking Alpha
Hologic, Inc. (NASDAQ:HOLX) Stake Boosted by Oppenheimer & Co. Inc.
Feb 08, 2024 13:06pm

Oppenheimer & Co. Inc. lifted its position in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 4.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,400 shares of the medical equipment provider’s stock after buying an additional 564 shares during the period. Oppenheimer & Co. Inc.’s […]

Source:The AM Reporter
Hologic CEO on Q1 earnings, AI in health care
Feb 05, 2024 18:08pm

Steve MacMillan, Hologic CE, joins ''Money Movers'' to discuss the company''s new AI cervical screening system, Hologic''s quarterly earnings results, and more.

Needham & Company LLC Raises Hologic (NASDAQ:HOLX) Price Target to $90.00
Feb 05, 2024 09:34am

Hologic (NASDAQ:HOLX – Free Report) had its price target hoisted by Needham & Company LLC from $83.00 to $90.00 in a report issued on Friday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. Several other research firms also recently weighed in on HOLX. Morgan Stanley dropped their target price […]

Source:The AM Reporter
7 Mutual Funds That Will Outperform in Any Market
Feb 03, 2024 18:49pm

While we’d all like to think that we’re secretly market geniuses and that no one knows it yet, the reality is that we could benefit from collectively pooled funds and that’s exactly what outperforming mutual funds offer. These (typically) actively managed investment vehicles provide diversification, helping to minimize losses while exposing you to potential upside opportunities. Sure, you could go it alone but that has a poor track record . Instead, along with the power of diversification, you could benefit from professional management. With outperforming mutual funds, investors gain access to experienced market experts who know how to navigate various storms and undulations based on their research and expertise. More often than not, education and experience win the day. Finally, mutual funds are convenience and liquid. You can easily buy and redeem these securities . Further, many funds offer automatic investment options for regular contributions. With myriad advantages and generally limited downsides, these outperforming mutual funds offer confidence during a still-confusing time.

FDA clears new cervical cytology AI tech from Hologic
Feb 02, 2024 17:51pm

… AI with advanced volumetric imaging technology to help identify pre-cancerous …

Source:EIN News Tech
Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Feb 02, 2024 12:33pm

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . JP Morgan cut the price target for WEC Energy Group, Inc. (NYSE: WEC ) from $90 to $84. JP Morgan analyst Jeremy Tonet downgraded the stock from Neutral to Underweight. WEC Energy shares gained 1.3% to close at $81.78 on Thursday. See how other analysts view this stock. Citigroup raised Macy''s, Inc. (NYSE: M ) price target from $14 to $18. Citigroup analyst Paul Lejuez upgraded the stock from Sell to Neutral. Macy''s shares rose 0.8% to close at $18.44 on Thursday. See how other analysts view this stock . Needham boosted the price target for Hologic, Inc. (NASDAQ: HOLX ) from $83 to $90. Needham analyst Mike Matson maintained a Buy rating. Hologic shares fell 0.1% to close at … Full story available on Benzinga.com

Hologic digital cytology system wins FDA approval
Feb 02, 2024 10:57am

No summary available.

Source:Seeking Alpha
Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript
Feb 02, 2024 03:56am

No summary available.

Source:Seeking Alpha
FDA clears Hologic''s AI-based cervical cancer screening system
Feb 01, 2024 23:36pm